Ignite Creation Date:
2024-05-06 @ 7:14 AM
Last Modification Date:
2024-10-26 @ 11:46 AM
Study NCT ID:
NCT02490072
Status:
COMPLETED
Last Update Posted:
2015-08-10
First Post:
2015-06-15
Brief Title:
Echocardiographic Evaluation of the Effects of Dexmedetomidine in Diastolic Dysfunction
Sponsor:
Yonsei University
Organization:
Yonsei University
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2015-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Dexmedetomidine is a selective α2 adrenergic agonist that can be considered a primary anesthetic an adjuvant to propofol or inhalational anesthetics Dexmedetomidine mediate its cardiovascular effect through activation of receptors in central and peripheral nervous system The classic cardiovascular response of dexmedetomidine is the biphasic with initial shorten-increase in blood pressure followed by long-lasting decrease in BP and HR There were several reports about these hemodynamic changs of dexmedetomidine but not the evaluation of direct cardiac function of patients who was preexisted diastolic dysfunction The purpose of this study is to evaluate the effects of dexmedetomidine as an anesthetic adjuvant in diastolic dysfunction by using the echocardiography
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None